Issue of Shares

Summary by AI ^BETAClose X

British American Tobacco PLC announced the issuance of 3,599 ordinary shares under its Sharesave Scheme between January 19 and March 16, 2026. These shares, ranking equally with existing ordinary shares, were admitted to the London Stock Exchange. Following this issuance, the company's total issued share capital stands at 2,173,748,098 shares with voting rights, and 132,976,327 shares are held in treasury.

Disclaimer*

British American Tobacco PLC

17 March 2026

British American Tobacco p.l.c. ("the Company")

17 March 2026

Issue of Shares

In accordance with PRM 1.6.4R, the Company (LEI: 213800FKA5MF17RJKT63) confirms that between 19 January 2026 and 16 March 2026 it has issued and allotted 3,599 ordinary shares of 25 pence each (ISIN GB0002875804) "Shares" in connection with the British American Tobacco p.l.c. Sharesave Scheme.

The Shares were admitted to trading on the London Stock Exchange Main Market under the Company's existing block admission of shares for this purpose dated 1 May 2015 (the "Block Admission"). 71,115 ordinary shares (not yet in issue) remain subject to the Block Admission.

The Shares rank equally and are fully fungible with the existing issued ordinary shares of the Company.

Following this issuance of Shares, the Company confirms that as at 16 March 2026, the Company's issued share capital consisted of 2,173,748,098 Shares with voting rights and 132,976,327 Shares held in Treasury.

N Jiang
Senior Assistant Company Secretary

Enquiries:

Media Centre

press_office@bat.com | @BATplc

Investor Relations

Victoria Buxton | IR_team@bat.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END